BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26567141)

  • 1. PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κB.
    Karyampudi L; Lamichhane P; Krempski J; Kalli KR; Behrens MD; Vargas DM; Hartmann LC; Janco JM; Dong H; Hedin KE; Dietz AB; Goode EL; Knutson KL
    Cancer Res; 2016 Jan; 76(2):239-50. PubMed ID: 26567141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer.
    Krempski J; Karyampudi L; Behrens MD; Erskine CL; Hartmann L; Dong H; Goode EL; Kalli KR; Knutson KL
    J Immunol; 2011 Jun; 186(12):6905-13. PubMed ID: 21551365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer.
    Peng J; Hamanishi J; Matsumura N; Abiko K; Murat K; Baba T; Yamaguchi K; Horikawa N; Hosoe Y; Murphy SK; Konishi I; Mandai M
    Cancer Res; 2015 Dec; 75(23):5034-45. PubMed ID: 26573793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer.
    Lamichhane P; Karyampudi L; Shreeder B; Krempski J; Bahr D; Daum J; Kalli KR; Goode EL; Block MS; Cannon MJ; Knutson KL
    Cancer Res; 2017 Dec; 77(23):6667-6678. PubMed ID: 28993412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
    Guo Z; Wang H; Meng F; Li J; Zhang S
    J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 1 open reading frame 190 promotes activation of NF-κB canonical pathway and resistance of dendritic cells to tumor-associated inhibition in vitro.
    Jing Z; Yuan X; Zhang J; Huang X; Zhang Z; Liu J; Zhang M; Oyang J; Zhang Y; Zhang Z; Yang R
    J Immunol; 2010 Dec; 185(11):6719-27. PubMed ID: 21048106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB regulates PD-1 expression in macrophages.
    Bally AP; Lu P; Tang Y; Austin JW; Scharer CD; Ahmed R; Boss JM
    J Immunol; 2015 May; 194(9):4545-54. PubMed ID: 25810391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
    Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
    Peek EM; Song W; Zhang H; Huang J; Chin AI
    Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer.
    Liu Y; Zeng B; Zhang Z; Zhang Y; Yang R
    Clin Immunol; 2008 Dec; 129(3):471-81. PubMed ID: 18790673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
    Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
    J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
    Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
    J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication.
    Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV
    J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.
    Abiko K; Matsumura N; Hamanishi J; Horikawa N; Murakami R; Yamaguchi K; Yoshioka Y; Baba T; Konishi I; Mandai M
    Br J Cancer; 2015 Apr; 112(9):1501-9. PubMed ID: 25867264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-κB.
    Gowrishankar K; Gunatilake D; Gallagher SJ; Tiffen J; Rizos H; Hersey P
    PLoS One; 2015; 10(4):e0123410. PubMed ID: 25844720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian Cancer-Intrinsic Fatty Acid Synthase Prevents Anti-tumor Immunity by Disrupting Tumor-Infiltrating Dendritic Cells.
    Jiang L; Fang X; Wang H; Li D; Wang X
    Front Immunol; 2018; 9():2927. PubMed ID: 30619288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8⁺ T cells.
    Kaiser AD; Schuster K; Gadiot J; Borkner L; Daebritz H; Schmitt C; Andreesen R; Blank C
    Eur J Immunol; 2012 Mar; 42(3):662-71. PubMed ID: 22144176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphatase SRC homology region 2 domain-containing phosphatase-1 is an intrinsic central regulator of dendritic cell function.
    Ramachandran IR; Song W; Lapteva N; Seethammagari M; Slawin KM; Spencer DM; Levitt JM
    J Immunol; 2011 Apr; 186(7):3934-45. PubMed ID: 21357539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural IgM Switches the Function of Lipopolysaccharide-Activated Murine Bone Marrow-Derived Dendritic Cells to a Regulatory Dendritic Cell That Suppresses Innate Inflammation.
    Lobo PI; Schlegel KH; Bajwa A; Huang L; Kurmaeva E; Wang B; Ye H; Tedder TF; Kinsey GR; Okusa MD
    J Immunol; 2015 Dec; 195(11):5215-26. PubMed ID: 26519533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy.
    Kobold S; Grassmann S; Chaloupka M; Lampert C; Wenk S; Kraus F; Rapp M; Düwell P; Zeng Y; Schmollinger JC; Schnurr M; Endres S; Rothenfußer S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26105028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.